Cap on drug price hikes for privately insured sparks battle
WASHINGTON — Workers and families with private health insurance would reap savings on prescription drugs from a little-noticed provision in [...]
The Astellas Global Health Foundation provides $1.85 million in funding to five organizations focused on improving health and COVID-19 recovery efforts for more than four million people in low-income communities
NORTHBROOK, Ill. , Nov. 17, The Astellas Global Health Foundation ("Foundation") announced today it will provide $1.85 million in combined [...]
Price Setting Bill Is No Panacea for Patients
The drug pricing deal in the Build Back Better Act sounded like welcome news to many. As someone who worked [...]
Ram Yeleswarapu to Drive Growth for Indegene Clinical and Enable Healthcare Organizations Digitalize their Clinical Development
Princeton, NJ, United States and Bangalore, KA, India, November 15 th, 2021 – Ram Yeleswarapu, a leading executive with over [...]
Why BlueCross is expanding our specialty pharmacy savings program
At BlueCross, we’re committed to delivering cost savings for members. And we know that during these last two years of [...]
How Rural Communities Are Losing Their Pharmacies
Batson’s Drug Store seems like a throwback to a simpler time. The independently owned pharmacy in Howard, Kansas, still runs [...]
Big Pharma Spent ‘Horrifying’ Sums of Money to Weaken Drug Price Reform
Pharmaceutical corporations and private health insurers spent $171 million on lobbying through the first nine months of the year, the [...]
The Biden bill limits drug price increases for privately insured people, but not everyone agrees.
The Biden bill limits drug price increases for privately insured people, but not everyone agrees. WASHINGTON — A little-noticed provision [...]
Big Pharma’s Favorite Democrats Saved the Drug Industry Half a Trillion Dollars
Big Pharma’s Favorite Democrats Saved the Drug Industry Half a Trillion Dollars Corporate Democrats like Senator Kyrsten Sinema saved Big [...]
Treatments of two rare diseases, debated at the largest congress on orphan drugs
The “World Orphan Drugs Congress” -the largest Congress of Orphan Medicines in the world- was held in Barcelona, at which [...]
Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse
Reykjavík, Iceland (ots/PRNewswire) – – The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby [...]
The Centenary of Insulin: Celebrating the Past, Analyzing the Present, and Looking into the Future
by: David Hirsch, MD and Aruna Muthumanickam, MBBS The discovery of insulin in 1921 revolutionized the medical treatment of diabetes, [...]
RWE in Pharma: Interview with Clare Hague, Janssen’s Therapy Area Market Access Leader for Hematology
On The Evidence Base’s RWE in Pharma, Claire Hague talks about the current impact of real-world data and evidence (RWD/RWE), [...]
Health Expenses: People dig deeper into their pockets
Health Expenses: People dig deeper into their pockets Bangladesh has the highest out-of-pocket (OOP) healthcare expenditure in South Asia except [...]
Alzheimer’s drug cited as Medicare premium jumps by $21.60
Alzheimer's drug cited as Medicare premium jumps by $21.60 By: Ricardo Alonso-zaldivar, The Associated Press Posted: 4:10 PM CST Friday, [...]
ISPOR Europe 2021 Poster Highlights: Evidence Base Differences, Cannabis Use in Schizophrenia, and RWD Demographics
On day one of the Virtual ISPOR Europe 2021 conference (November 30th), researchers Harrison et al. presented work examining the [...]
Oncology RWE Fitness Assessments Accelerated by Multisource Datasets
In response to an article in Values & Outcomes Spotlight, Mary Tran discusses how a multisource data strategy may streamline [...]
Could This Bombshell Case Expose a Cancer of Corruption Festering within the Global Health System?
I ended my previous article with this little gem from the British Medical Journal….. https://unitynewsnetwork.co.uk/without-data-it-is-not-science/ The story that has just [...]
Only 15% of Health Systems and Insurance CEOs are Women
The gender divide is pronounced in leadership positions in the health systems and insurance groups, results from a JAMA Network [...]
Outside the Box: Middlemen, not drug companies, are pushing up insulin prices, and Congress doesn’t have the right plan to fight back
To generate outrage over drug prices, it’s hard to beat the example of insulin. This life-saving drug is 100 years [...]
The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine
Review Article | Open Access Jie Zhang, Zong-Ming Zhang, "The Challenges of Ethical Review in Clinical Research of Traditional Chinese [...]
Cap on drug price hikes for privately insured sparks battle – Netscape Money & Business
By RICARDO ALONSO-ZALDIVAR Associated Press WASHINGTON (AP) — Workers and families with private health insurance would reap savings on prescription [...]
Healthcare Informatics Market to Receive Overwhelming Hike in Revenues by 2031
Healthcare Informatics Market: Introduction According to the report, the global healthcare informatics market was valued at US$ 31 Bn in [...]
“Enabling Stakeholders Who Support the Patient” Asembia 2021 Keynote Recap
The opportunities afforded by specialty pharmacy and telehealth for providers to improve patient care were the subject of the October [...]
Commentary: Public opinion is unified on lowering prescription drug prices — why are Democrats settling for less? | Op Eds
Democrats and Republicans are crystal clear in polls that they want government to be allowed to negotiate down high drug [...]